210 related articles for article (PubMed ID: 11291556)
1. Herceptin: from the bench to the clinic.
Colomer R; Shamon LA; Tsai MS; Lupu R
Cancer Invest; 2001; 19(1):49-56. PubMed ID: 11291556
[No Abstract] [Full Text] [Related]
2. Herceptin raises its sights beyond advanced breast cancer.
McNeil C
J Natl Cancer Inst; 1998 Jun; 90(12):882-3. PubMed ID: 9637135
[No Abstract] [Full Text] [Related]
3. [Trastuzumab for treatment of advanced breast cancers].
Watanabe T; Shimizu C; Katsumata N; Saijo N
Nihon Rinsho; 2000 Apr; 58 Suppl():340-4. PubMed ID: 11026016
[No Abstract] [Full Text] [Related]
4. [Docetaxel (Taxotere) in combination with trastuzumab (Herceptin)].
Ficorella C
Tumori; 2001; 87(1 Suppl 2):S10-8. PubMed ID: 11357872
[No Abstract] [Full Text] [Related]
5. New molecule-targeting therapy with herceptin (trastuzumab), an anti-HER2 (c-erB-2) monoclonal antibody.
Sakamoto G; Mitsuyama S
Breast Cancer; 2000; 7(4):350-7. PubMed ID: 11114864
[No Abstract] [Full Text] [Related]
6. Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Rowan K
J Natl Cancer Inst; 2009 Apr; 101(7):448-9. PubMed ID: 19318626
[No Abstract] [Full Text] [Related]
7. Herceptin and the heart--a molecular modifier of cardiac failure.
Chien KR
N Engl J Med; 2006 Feb; 354(8):789-90. PubMed ID: 16495390
[No Abstract] [Full Text] [Related]
8. [Breast cancer].
Tokuda Y; Saito Y; Suzuki Y; Ohta M; Tajima T
Nihon Rinsho; 2002 Mar; 60(3):563-9. PubMed ID: 11904974
[TBL] [Abstract][Full Text] [Related]
9. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Yaal-Hahoshen N; Safra T
Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
[No Abstract] [Full Text] [Related]
10. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
Mallmann P
Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
[No Abstract] [Full Text] [Related]
11. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group.
Shak S
Semin Oncol; 1999 Aug; 26(4 Suppl 12):71-7. PubMed ID: 10482196
[TBL] [Abstract][Full Text] [Related]
12. Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials.
Baselga J
Oncology; 2001; 61 Suppl 2():14-21. PubMed ID: 11694783
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab faces trials, clinical and otherwise.
Tuma RS
J Natl Cancer Inst; 2006 Mar; 98(5):296-8. PubMed ID: 16507822
[No Abstract] [Full Text] [Related]
14. Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer.
Emens LA
Am J Ther; 2005; 12(3):243-53. PubMed ID: 15891269
[TBL] [Abstract][Full Text] [Related]
15. From the molecule to the clinic--inhibiting HER2 to treat breast cancer.
Eisenhauer EA
N Engl J Med; 2001 Mar; 344(11):841-2. PubMed ID: 11248162
[No Abstract] [Full Text] [Related]
16. Herceptin in elderly patients.
Bighin C; Stevani I; Venturini M
Tumori; 2002; 88(1 Suppl 1):S37-8. PubMed ID: 11989920
[No Abstract] [Full Text] [Related]
17. Herceptin produces clinical benefit in metastatic breast cancer regardless of tumor response.
Oncology (Williston Park); 2004 Aug; 18(9):1201. PubMed ID: 15471203
[No Abstract] [Full Text] [Related]
18. Controversies in the use of adjuvant trastuzumab (Herceptin).
Chowdhury S; Pickering L; Ellis P
J Br Menopause Soc; 2006 Dec; 12(4):172-4. PubMed ID: 17178019
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from Herceptin trials in metastatic breast cancer?
Bell R
Oncology; 2002; 63 Suppl 1():39-46. PubMed ID: 12422054
[TBL] [Abstract][Full Text] [Related]
20. Herceptin: help for advanced breast cancer.
Runowicz CD
Health News; 2001 May; 7(5):4. PubMed ID: 11851153
[No Abstract] [Full Text] [Related]
[Next] [New Search]